BRIM Biotechnology, Inc. (TPE:6885)
Taiwan · Delayed Price · Currency is TWD 23.65
-0.30 (-1.25%)
At close: Mar 23, 2026
BRIM Biotechnology Market Cap
BRIM Biotechnology has a market cap or net worth of 3.15 billion as of March 24, 2026. Its market cap has decreased by -23.31% in one year.
Market Cap
3.15B
Enterprise Value
2.10B
Revenue
5.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.65
Market Cap Chart
Since June 23, 2022, BRIM Biotechnology's market cap has increased from 1.77B to 3.15B, an increase of 78.40%. That is a compound annual growth rate of 16.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 3.15B | -20.50% |
| Dec 31, 2025 | 3.96B | -2.58% |
| Dec 31, 2024 | 4.07B | 17.34% |
| Dec 29, 2023 | 3.47B | -2.55% |
| Dec 30, 2022 | 3.56B | 101.45% |
| Jun 23, 2022 | 1.77B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Pharmaceuticals | 3.90B |
| ACRO Biomedical | 3.78B |
| Genovate Biotechnology | 3.45B |
| Sagittarius Life Science | 3.40B |
| Shine-On BioMedical | 3.33B |
| SYN-TECH Chem. & Pharm. | 3.22B |
| Intech Biopharm | 3.03B |
| Syngen Biotech | 2.93B |